Liver Diseases  >>  irbesartan  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
irbesartan / Generic mfg.
Fibrosar, NCT00265642: Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C

Completed
3
166
Europe
Irbesartan, placebo
ANRS, Emerging Infectious Diseases, Sanofi
Hepatitis C, Chronic
04/13
11/13

Download Options